Summary
Strides Shasun Ltd (Strides Shasun), formerly Strides Arcolab Limited, which offers generic products. It focuses on the development and manufacture of intellectual property -led pharmaceutical products. Strides Shasun manufactures drugs in various oral dosage forms such as general tablets, hard gelatin capsules and soft gelatin capsules and potent drugs. The company provides services in various areas which include pharma generics, bio generics and branded generics. Strides Shasun’s products find applications in the treatment of diseases such as AIDS, malaria and tuberculosis. It also works in partnership with other organizations to develop novel drugs. The company operates through its sites and research and development hubs in Bangalore. Strides Shasun is headquartered in Bangalore, Karnataka, India.
Strides Shasun Ltd (STAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Strides Shasun Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 7
Strides Shasun Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 8
Strides Shasun Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 9
Strides Shasun Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 10
Strides Shasun Ltd, Medical Devices Deals, 2010 to YTD 2016 12
Strides Shasun Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 13
Strides Shasun Ltd, Pharmaceuticals & Healthcare, Deal Details 16
Asset Purchase 16
Strides Shasun Acquires Jointflex, Fergon and Vanquish Brands from Moberg Pharma for USD10 Million 16
Strides Arcolab to Acquire Seven Brands from Johnson & Johnson 18
Strides Arcolab to Acquire Ranbaxy's CNS Business from Sun Pharma for USD25 Million 19
Strides Arcolab Acquires Generic Pharma Business and Related Assets from Aspen Pharmacare for USD210 Million 20
Strides Arcolab Acquires Prescription Products from Aspen Global for USD92 million 22
Strides Arcolab to Acquire 74% Stake in Branded Generics Unit of Bafna Pharma for USD8 Million 23
Strides Arcolab Acquires Sterile Drugs Manufacturing Facility From Star Drugs and Research Labs For US$23.5 Million 24
Strides Acquires Brazilian Manufacturing Facility From Aspen Pharmacare 25
Private Equity 26
Apax Partners Acquires 1.2% stake in Strides Arcolab for USD8 Million 26
Partnerships 27
Medicines for Malaria Venture Enters into Agreement with Cipla and Strides Arcolab 27
Strides Arcolab Forms Joint Venture With Bio-XCell 28
Strides Arcolab Enters Into Joint Venture Agreement With BioChimico 29
Pfizer Enters Into Co-Marketing Agreement With Strides Arcolab 30
Merger 31
Strides Arcolab to Merge with Shasun Pharma 31
Licensing Agreements 32
Gilead Sciences Enters into Licensing Agreement with Strides Arcolab 32
Gilead Sciences Enters into Licensing Agreement with Strides Arcolab 33
Pfenex Enters into Licensing Agreement with Strides Arcolab 35
Strides Arcolab Enters Into Licensing Agreement With Eli Lilly For Generic Cancer Medicines 36
Strides Arcolab Enters Into Licensing Agreement With Gilead Sciences For Generic Versions Of Emtricitabine 37
Gilead Sciences Extends Licensing Agreement With Strides Arcolab For Tenofovir, Elvitegravir, Cobicistat And Quad 39
Strides Arcolab Enters Into Licensing Agreement With Pfizer 41
Equity Offering 42
Strides Arcolab Invests in Oncobiologics 42
Strides Arcolab Completes Private Placement Of US$100 Million 43
Asset Transactions 45
Moberg Pharma to Acquire PediaCare Brands from Strides Pharma 45
Zydus Cadila Healthcare To Acquire Domestic Generic Business From Strides Arcolab 46
Acquisition 47
Strides Shasun to Acquire Perrigo API India from Perrigo for USD14.8 Million 47
Strides Shasun Acquires 51% Stake in Generic Partners 48
Strides Shasun Acquires 51% Stake in Universal Corporation for USD14 Million 49
Strides Shasun to Sell its Shasun Pharma Solutions 50
Strides Arcolab to Acquire Majority Stake in Medispan 51
GMS to Acquire 25.1% Stake in Stelis Biopharma from Strides Arcolab for USD22 Million 52
Mylan Completes Acquisition Of Agila Specialties From Strides Arcolab For Up To US$1.75 Billion 53
PROPARCO Acquires 20% Stake In Strides Africa From Strides Arcolab For US$13 Million 56
Watson Pharma Acquires Ascent Pharmahealth From Strides Arcolab And Dennis Bastas For US$394 Million 57
Strides Arcolab Completes Acquisition Of Additional 33.7% Stake In Ascent Pharmahealth For US$33 Million 59
Strides Arcolab Acquires 70% Stake In Inbiopro Solutions 61
Strides Acquires 50% Stake In Onco Therapies And Onco Labs From Aspen 63
Strides Shasun Ltd - Key Competitors 64
Key Employees 65
Locations And Subsidiaries 66
Head Office 66
Other Locations & Subsidiaries 66
Appendix 68
Methodology 68
About GlobalData 68
Contact Us 68
Disclaimer 68
List of Tables
Strides Shasun Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Strides Shasun Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 7
Strides Shasun Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 8
Strides Shasun Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 9
Strides Shasun Ltd, Deals By Therapy Area, 2010 to YTD 2016 10
Strides Shasun Ltd, Medical Devices Deals, 2010 to YTD 2016 12
Strides Shasun Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 13
Strides Shasun Acquires Jointflex, Fergon and Vanquish Brands from Moberg Pharma for USD10 Million 16
Strides Arcolab to Acquire Seven Brands from Johnson & Johnson 18
Strides Arcolab to Acquire Ranbaxy's CNS Business from Sun Pharma for USD25 Million 19
Strides Arcolab Acquires Generic Pharma Business and Related Assets from Aspen Pharmacare for USD210 Million 20
Strides Arcolab Acquires Prescription Products from Aspen Global for USD92 million 22
Strides Arcolab to Acquire 74% Stake in Branded Generics Unit of Bafna Pharma for USD8 Million 23
Strides Arcolab Acquires Sterile Drugs Manufacturing Facility From Star Drugs and Research Labs For US$23.5 Million 24
Strides Acquires Brazilian Manufacturing Facility From Aspen Pharmacare 25
Apax Partners Acquires 1.2% stake in Strides Arcolab for USD8 Million 26
Medicines for Malaria Venture Enters into Agreement with Cipla and Strides Arcolab 27
Strides Arcolab Forms Joint Venture With Bio-XCell 28
Strides Arcolab Enters Into Joint Venture Agreement With BioChimico 29
Pfizer Enters Into Co-Marketing Agreement With Strides Arcolab 30
Strides Arcolab to Merge with Shasun Pharma 31
Gilead Sciences Enters into Licensing Agreement with Strides Arcolab 32
Gilead Sciences Enters into Licensing Agreement with Strides Arcolab 33
Pfenex Enters into Licensing Agreement with Strides Arcolab 35
Strides Arcolab Enters Into Licensing Agreement With Eli Lilly For Generic Cancer Medicines 36
Strides Arcolab Enters Into Licensing Agreement With Gilead Sciences For Generic Versions Of Emtricitabine 37
Gilead Sciences Extends Licensing Agreement With Strides Arcolab For Tenofovir, Elvitegravir, Cobicistat And Quad 39
Strides Arcolab Enters Into Licensing Agreement With Pfizer 41
Strides Arcolab Invests in Oncobiologics 42
Strides Arcolab Completes Private Placement Of US$100 Million 43
Moberg Pharma to Acquire PediaCare Brands from Strides Pharma 45
Zydus Cadila Healthcare To Acquire Domestic Generic Business From Strides Arcolab 46
Strides Shasun to Acquire Perrigo API India from Perrigo for USD14.8 Million 47
Strides Shasun Acquires 51% Stake in Generic Partners 48
Strides Shasun Acquires 51% Stake in Universal Corporation for USD14 Million 49
Strides Shasun to Sell its Shasun Pharma Solutions 50
Strides Arcolab to Acquire Majority Stake in Medispan 51
GMS to Acquire 25.1% Stake in Stelis Biopharma from Strides Arcolab for USD22 Million 52
Mylan Completes Acquisition Of Agila Specialties From Strides Arcolab For Up To US$1.75 Billion 53
PROPARCO Acquires 20% Stake In Strides Africa From Strides Arcolab For US$13 Million 56
Watson Pharma Acquires Ascent Pharmahealth From Strides Arcolab And Dennis Bastas For US$394 Million 57
Strides Arcolab Completes Acquisition Of Additional 33.7% Stake In Ascent Pharmahealth For US$33 Million 59
Strides Arcolab Acquires 70% Stake In Inbiopro Solutions 61
Strides Acquires 50% Stake In Onco Therapies And Onco Labs From Aspen 63
Strides Shasun Ltd, Key Competitors 64
Strides Shasun Ltd, Key Employees 65
Strides Shasun Ltd, Other Locations 66
Strides Shasun Ltd, Subsidiaries 66
List of Figures
Strides Shasun Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Strides Shasun Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Strides Shasun Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Strides Shasun Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Strides Shasun Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 7
Strides Shasun Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 8
Strides Shasun Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 9
Strides Shasun Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 10
Strides Shasun Ltd, Medical Devices Deals, 2010 to YTD 2016 12
